期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中心体微管蛋白异常与肿瘤研究进展 被引量：1

暂未订购
导出
作者 王慧 牛昀
机构地区 南开大学医学院 天津医科大学肿瘤医院国家教育部乳腺癌防治重点实验室
出处 《诊断学理论与实践》 2006年第4期362-364,共3页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金项目资助(30471967)
关键词 中心体 微管蛋白 肿瘤
分类号 R730.1 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1[1]Doxsey S.Re-evaluating centrosome function[J].Nat Rev Mol Cell Biol,2001,2(9):688-698.
  • 2[2]D'Assoro AB,Lingle WL,Salisbury JL.Centrosome amplification and the development of cancer[J].Oncogene,2002,21 (40):6146-6153.
  • 3[3]Lothschutz D,Jennewein M,Pahl S,et al.Polyploidization and centrosome hyperamplification in inflammatory bronchi[J].Inflamm Res,2002,51(8):416-422.
  • 4[4]Duensing S,Lee BH,Dal Cin P,et al.Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma[J].Mol Cancer,2003,2(1):30.
  • 5[5]Martin-Subero JI,Knippschild U,Harder L,et al.Segmental chromosomal aberrations and centrosome amplifications:pathogenetic mechanisms in Hodgkin and ReedSternberg cells of classical Hodgkin's lymphoma[J].Leukemia,2003,17(11):2214-2219.
  • 6[6]Duensing S.A tentative classification of centrosome abnormalities in cancer[J].Cell Biol Int,2005,29 (5):352-359.
  • 7唐晓玲,缪时英.微管成核的研究进展[J].生命的化学,2004,24(2):123-125. 被引量：3
  • 8[8]McKean PG,Vaughan S,Gull K.The extended tubulin superfamily[J].J Cell Sci,2001,114(Pt 15):2723-2733.
  • 9[9]Dozier JH,Hiser L,Davis JA,et al.Beta class Ⅱ tubulin predominates in normal and tumor breast tissues[J].Breast Cancer Res,2003,5(5):R157-R169.
  • 10[10]Papaconstantinou AD,Shanmugam I,Shan L,et al.Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene[J].Int J Cancer,2006,118(1):17-24.

二级参考文献33

  • 1Fukasawa K. Introduction. Centrosome. Oncogene, 2002, 21:6140-6145.
  • 2Bornens M. Centrosome compsition and microtubule anchoring mechanisms. Curr Opin Cell Biol, 2002,14: 25-34.
  • 3Katayama H, Brinkley WR, Sen S. The Aurora kinases : role in cell transformation and tumorigenesis. Cancer Metastasis Rev, 2003,22 :451-464.
  • 4D'Assoro AB, Barrett SL, Folk C, et al. Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res Treat, 2002, 75:25-34.
  • 5Kawamura K, Moriyama M, Shiba N, et al. Centrosome hyperamplification and chromosomal instability in bladder cancer.Eur Urol, 2003,43:505-515.
  • 6Tavassoli FA, Devilee P, eds. The WHO classification of tumors of the breast and female genital organs. Lyon: IARC Press, 2003. 10-112.
  • 7Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000, 6:127-134.
  • 8Schneeweiss A, Sinn HP, Ehemann V, et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer, 2003,107:346-352.
  • 9Page DL, Jensen RA, Simpson JF, et al. Historical and epidemiologic background of human premalignant breast disease.J Mammary Gland Biol Neoplasia,2000, 5:341-349.
  • 10Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Can, 2002, 2:815-825.

共引文献12

同被引文献6

引证文献1

诊断学理论与实践
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部